NASDAQ: ALNY · Biotechnology
Over the past week, Alnylam Pharmaceuticals (ALNY) racked up about 22 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 68% bullish but is far apart: News runs 100% bullish while Reddit sits at just 50%. Wall Street is more constructive, with 23 of 29 analysts rating ALNY a buy.
There is little buzz around ALNY this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 79% buy share sits next to a crowd that ranges from Reddit at 50% to News at 100%. No other tracker puts the two side by side.
Across 29 analysts the consensus is a Strong Buy: 23 buy calls against 0 sell, with an average 12-month price target of $370.20.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 11 points above the crowd average of 68%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while Reddit sits at 50%, a 50-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Alnylam Pharmaceuticals (ALNY) buzz held subdued around 36.1 while the price drifted up 23.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.7M shares. Over the last 7 trading days, ALNY gained 12.5%. Buzz activity in the recent week averaged 32.8 and was relatively stable, swinging between 20.2 and 38.3. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 10 of the 19 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ALNY and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ALNY sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 09, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (23 / 6 / 0) |
| Crowd bullish (7d) | 68% |
| Avg price target | $370.20 |
| Most bullish source | News, 100% |
| Most bearish source | Reddit, 50% |
| Sentiment spread | 50 pts |
| Mentions (7d) | 22 |
| Market cap | $35.78B |
| P/E · Forward P/E | 42.9 · 19.3 |
| EPS · Beta | $6.23 · 0.3 |
| Revenue (TTM) | $4.8B · 16% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Alnylam Pharmaceuticals (ALNY) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 68% bullish across 3 active sources. Those sources contribute 22 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Alnylam Pharmaceuticals (ALNY) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Alnylam Pharmaceuticals (ALNY), averaging 68% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and Reddit at 50%, a 50-point spread. On the professional side, 23 of 29 analysts rate ALNY a buy.
Of the 29 analysts covering Alnylam Pharmaceuticals (ALNY), 23 rate it a buy, 6 a hold and 0 a sell, for a strong buy consensus. The average price target is $370.20. That puts the street ahead of the crowd, which averages 68% bullish.
Alnylam Pharmaceuticals (ALNY)'s cross-source average is bullish at 68% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. X reads 54% bullish, News reads 100% bullish and reddit coverage is the most negative at 50% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Alnylam Pharmaceuticals (ALNY) at 68% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. The most bearish reading is reddit at 50% bullish. 3-day activity momentum is falling on X, while news activity is rising. The buy signal carries 93/100 conviction.
X is the dominant discussion channel with 13 mentions (59% of total volume). News contributes 7 mentions and Reddit contributes 2 mentions. The cross-source average is bullish at 68% bullish, while news is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ALNY's buy signal at 93/100 conviction reflects a bullish cross-source average at 68% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The ALNY sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key